{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:57:23Z","timestamp":1795111043213,"version":"4.10.3"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Pain is the most common and often most troublesome feature of chronic autoimmune diseases such as psoriatic arthritis (PsA) and axial spondyloarthritis (AxSpA). A predominant concept is that the main source of pain is from disease-induced tissue inflammation and structural damage, activating peripheral nerve fibers which relay to the central nervous system. This mechanism is nociceptive pain and the presumption has been that controlling inflammation will be sufficient to reduce this form of pain. However, despite control of inflammation, patients may still have significant residual pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>We are learning that there are additional pain mechanisms, neuropathic and nociplastic, that are often operative in patients with rheumatologic conditions, that can significantly influence pain experience, quantitation of disease activity, and may benefit from therapeutic approaches distinct from immunotherapy. Neuropathic pain arises from diseased or damaged nerve tissue and nociplastic pain reflects sensitization of the central nervous system due to multiple genetic, neurobiologic, neural network dysregulation, and psychosocial factors. Pain arising from these mechanisms influence assessment of disease activity and thus needs to be factored into decision-making about immunotherapy efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This review addresses the importance of accurately assessing the complex mechanisms of pain experience in patients with PsA and AxSpA to more appropriately manage immunomodulatory, neuromodulatory, and nonpharmacologic therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001023","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T08:00:06Z","timestamp":1714550406000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis"],"prefix":"10.1097","volume":"36","author":[{"given":"Philip J.","family":"Mease","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.berh.2019.04.007","article-title":"New concepts of pain","volume":"33","author":"Trouvin","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2020.12.007","article-title":"Pain in axial spondyloarthritis: insights from immunology and brain imaging","volume":"47","author":"Pathan","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1185\/03007995.2016.1157460","article-title":"The painDETECT project \u2013 far more than a screening tool on neuropathic pain","volume":"32","author":"Freynhagen","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/BOR.0000000000000388","article-title":"Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment","volume":"29","author":"Mease","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/rheumatology\/keac671","article-title":"Non-inflammatory pain in inflammatory arthritis","volume":"62","author":"Das","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","article-title":"Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST)","volume":"150","author":"Perrot","year":"2010","journal-title":"Pain"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1533-2500.2011.00493.x","article-title":"The development and psychometric validation of the central sensitization inventory","volume":"12","author":"Mayer","year":"2012","journal-title":"Pain Pract"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/art.34412","article-title":"Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia","volume":"64","author":"Napadow","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.27497","article-title":"Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity","volume":"62","author":"Napadow","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"(S9)","key":"R15-20250526","first-page":"4487","article-title":"Increased brain functional connectivity to the insula is associated with nociplastic pain in psoriatic arthritis","volume":"74","author":"Sunzini","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s00429-015-1161-1","article-title":"Abnormal cross-network functional connectivity in chronic pain and its association with clinical symptoms","volume":"221","author":"Hemington","year":"2016","journal-title":"Brain Struct Funct"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.0098-07.2007","article-title":"Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?","volume":"27","author":"Kuchinad","year":"2007","journal-title":"J Neurosci"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/01.wnl.0000295509.30630.10","article-title":"Cortical thinning in IBS: implications for homeostatic, attention, and pain processing","volume":"70","author":"Davis","year":"2008","journal-title":"Neurology"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.37920","article-title":"Neuropathic pain in ankylosing spondylitis: a psychophysics and brain imaging study","volume":"65","author":"Wu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/art.27585","article-title":"Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study","volume":"62","author":"Gwilym","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"(S9)","key":"R22-20250526","first-page":"2394","article-title":"Prevalence and impact of widespread pain and fibromyalgia on measurement of disease severity in psoriatic arthritis: lessons from the CorEvitas Registry","volume":"74","author":"Mease","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.151491","article-title":"The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study","volume":"43","author":"Brikman","year":"2016","journal-title":"J Rheumatol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/acr.20155","article-title":"Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data","volume":"62","author":"Coates","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/acr.23693","article-title":"Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: a prospective cohort study","volume":"71","author":"Hojgaard","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1590\/S0482-50042010000600005","article-title":"Occurrence of fibromyalgia in patients with ankylosing spondylitis","volume":"50","author":"Azevedo","year":"2010","journal-title":"Rev Brasil Reumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1097\/RHU.0000000000001490","article-title":"The American College of Rheumatology fibromyalgia criteria are useful in the evaluation of fibromyalgia symptoms in patients with ankylosing spondylitis: a cross-sectional study","volume":"27","author":"Magrey","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"e004009","DOI":"10.1136\/rmdopen-2023-004009","article-title":"Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs","volume":"10","author":"Al Mohamad","year":"2024","journal-title":"RMD Open"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3899\/jrheum.090805","article-title":"Disease activity composite indices in patients with rheumatoid arthritis and concomitant fibromyalgia","volume":"37","author":"Toms","year":"2010","journal-title":"J Rheumatol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3899\/jrheum.220046","article-title":"Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis","volume":"49","author":"Moore","year":"2022","journal-title":"J Rheumatol"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semarthrit.2014.01.001","article-title":"Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI","volume":"44","author":"Cagnie","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","article-title":"Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: results of a prospective, multicentre study","volume":"77","author":"Molto","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s40744-022-00482-5","article-title":"Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis","volume":"9","author":"de Vlam","year":"2022","journal-title":"Rheumatol Ther"},{"issue":"(S9)","key":"R34-20250526","article-title":"Direct and indirect effects of upadacitinib or adalimumab on pain in psoriatic arthritis: Results from a randomized Phase 3 study","volume":"75","author":"Taylor","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"(S9)","key":"R35-20250526","article-title":"Assessment of direct and indirect impact on pain and fatigue outcomes in a phase 2 clinical trial of deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in patients with active PsA: a mediation analysis","volume":"75","author":"Mease","year":"2023","journal-title":"ACR Convergence"},{"issue":"(S9)","key":"R36-20250526","article-title":"Ixekizumab shows a distinct pattern of pain improvement beyond measurable inflammation as assessed by MRI or CRP or BASDAI questions 5 & 6 in patients with ankylosing spondylitis","volume":"73","author":"de Vlam","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pain.2013.07.039","article-title":"Deconstructing sex differences in pain sensitivity","volume":"155","author":"Hashmi","year":"2014","journal-title":"Pain"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/j.pain.0000000000002104","article-title":"Sex differences in brain modular organization in chronic pain","volume":"162","author":"Fauchon","year":"2021","journal-title":"Pain"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/S2665-9913(23)00264-3","article-title":"Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis","volume":"5","author":"Eder","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"(Suppl4)","key":"R40-20250526","doi-asserted-by":"crossref","first-page":"iv38","DOI":"10.1093\/rheumatology\/keaa543","article-title":"Sex and gender differences in axial spondyloarthritis: myths and truths","volume":"59","author":"Rusman","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-023-06605-9","article-title":"Difficult to treat psoriatic arthritis \u2013 how should we manage?","volume":"42","author":"Kumthekar","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"e003809","DOI":"10.1136\/rmdopen-2023-003809","article-title":"Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project","volume":"10","author":"Singla","year":"2024","journal-title":"RMD Open"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"105670","DOI":"10.1016\/j.jbspin.2023.105670","article-title":"Characteristics of difficult-to-treat axial spondyloarthritis: results of a real-world multicentric study","volume":"91","author":"Philippoteaux","year":"2023","journal-title":"Joint Bone Spine"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.40391","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) outcome measures in rheumatology consensus-based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis","volume":"70","author":"Coates","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/j.pain.0000000000002466","article-title":"Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial","volume":"163","author":"Vela","year":"2022","journal-title":"Pain"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:16:25Z","timestamp":1748279785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001023","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}